KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Goodwill (2018 - 2025)

Vir Biotechnology's Goodwill history spans 8 years, with the latest figure at $16.9 million for Q3 2025.

  • For Q3 2025, Goodwill changed 0.01% year-over-year to $16.9 million; the TTM value through Sep 2025 reached $16.9 million, changed 0.01%, while the annual FY2024 figure was $16.9 million, 0.0% changed from the prior year.
  • Goodwill for Q3 2025 was $16.9 million at Vir Biotechnology, roughly flat from $16.9 million in the prior quarter.
  • Across five years, Goodwill topped out at $16.9 million in Q3 2024 and bottomed at $16.9 million in Q1 2021.
  • The 5-year median for Goodwill is $16.9 million (2021), against an average of $16.9 million.
  • The largest annual shift saw Goodwill grew 0.01% in 2024 before it decreased 0.01% in 2025.
  • A 5-year view of Goodwill shows it stood at $16.9 million in 2021, then changed by 0.0% to $16.9 million in 2022, then changed by 0.0% to $16.9 million in 2023, then changed by 0.0% to $16.9 million in 2024, then changed by 0.0% to $16.9 million in 2025.
  • Per Business Quant, the three most recent readings for VIR's Goodwill are $16.9 million (Q3 2025), $16.9 million (Q2 2025), and $16.9 million (Q1 2025).